Skip to main content

Table 1 Clinical characteristics of patients with type 2 diabetes by gender

From: Clinical relevance of dual-energy X-ray absorptiometry (DXA) as a simultaneous evaluation of fatty liver disease and atherosclerosis in patients with type 2 diabetes

 

Male (N = 155)

Female (N = 104)

p value

Age (years)

63 ± 12

64 ± 13

0.570

Body mass index (kg/m2)

25.1 ± 4.1

24.2 ± 4.4

0.128

HbA1c (%)

7.2 ± 1.4

7.1 ± 1.5

0.600

Duration of diabetes (years)

7 (2–16)

7 (3–10)

0.958

Current smoker (%)

21

3

0.023

Proliferative diabetic retinopathy (%)

8

10

0.423

Insulin (%)

30

36

0.358

Systolic blood pressure (mmHg)

129 ± 14

124 ± 15

0.442

Diastolic blood pressure (mmHg)

77 ± 13

71 ± 15

0.338

Uninary ACR (mg/g)

33 (20–148)

26 (13–54)

0.209

eGFR (ml/min/1.73 m2)

75 ± 12

69 ± 13

<0.001

TG (mmol/l)

1.48 (1.30–1.71)

1.22 (1.02–1.47)

0.045

HDL cholesterol (mmol/l)

1.45 ± 0.38

1.60 ± 0.47

0.002

LDL cholesterol (mmol/l)

2.64 (2.19–3.17)

2.69 (2.17–3.72)

0.308

Uric acid (μmol/l)

333 ± 77

286 ± 65

<0.001

AST (U/l)

25 (20–34)

22 (18–28)

0.402

ALT (U/l)

26 (16–45)

20 (15–33)

0.047

γ-GTP (U/l)

42 (31–53)

30 (20–40)

<0.001

Body fat (%)

30.8 ± 6.8

38.7 ± 7.2

<0.001

Skeletal muscle index

7.2 ± 1.1

5.8 ± 1.0

<0.001

Android (kg)

2.1 (1.1–3.3)

1.9 (1.5–2.9)

0.098

Gynoid (kg)

2.7 (1.9–3.8)

3.3 (2.5–4.1)

0.006

A/G ratio

0.74 ± 0.18

0.59 ± 0.19

<0.001

Visceral fat area (cm2)

153 (95–228)

126 (104–169)

0.002

Subcutaneous fat area (cm2)

141 (74–231)

194 (150–252)

<0.001

V/S ratio

1.14 ± 0.50

0.65 ± 0.32

<0.001

Liver attenuation index

1.08 ± 0.22

1.17 ± 0.29

0.303

  1. ACR albumin-to-creatinine ratio, A/G android-to-gynoid, ALT alanine aminotransferase, AST Aspartate aminotransferase, eGFR estimated glomerular filtration rate, γ-GTP γ-glutamyl transpeptidase, HDL high-density lipoprotein, LAI liver attenuation index, LDL low-density lipoprotein, V/S visceral-to-subcutaneous fat